One hour observation of patients after image-guided percutaneous renal mass biopsy

Acta Radiologica Open

Original Article

Anders Elgborn¹  Benjamin S Rasmussen²  John Valtersson²  Ole Graumann²  Lars Lund³ 

[1] Department of Radiology, , Aabenraa, Denmark;Department of Radiology, , Odense C, Denmark;Research and Innovation Unit of Radiology, , Odense C, Denmark;Department of Urology, , Odense C, Denmark;Institute of Clinical Research, , Odense C, Denmark;

关键词: renal mass;    renal cell carcinoma;    biopsy;    image-guided;    observation;    monitor;   

DOI  :  10.1177/20584601221138555

 received in 2022-10-21, accepted in 2022-10-26,  发布年份 2022

来源: Sage Journals

【 摘 要 】

BackgroundImaging-guided percutaneous biopsy of renal masses is regarded as safe and is widely used for histopathology diagnosis before treatment. Recommended observation time after tumour biopsy varies in international guidelines and the literature is sparse.PurposeTo assess the effect of a 1-h post-biopsy observation time of percutaneous image-guided renal mass biopsy.Material and MethodsThis was a single-centre retrospective study. During January 2015 to September 2019, a total of 484 patients underwent renal mass biopsies. 4-h-observation-group: 178 patients and 1-h-observation-group 306 patients. All records were retrospectively reviewed, and data such as complications was obtained and compared between the two groups.ResultsA total complication rate of 4.5% (n = 22) without any major complications (Cardiovascular and Interventional Radiological Society of Europe-grade (CIRSE) 5–6). Furthermore, a non-significant difference of 1.3% of the 1-h group and 3.4% in the 4-h group experiencing complications was found (p = .18). A total biopsy-accuracy of 84% was observed.ConclusionThis study shows that renal mass biopsy is safe with no major complications. This suggests that an outpatient approach with 1-h-observation time can be safely implemented for renal mass biopsy.

【 授权许可】

CC BY-NC   
© The Author(s) 2022

【 图 表 】

Figure 4.

Figure 3.

Figure 2.

Figure 2.

Figure 2.